Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.

ClinicalTrials.gov ID: NCT05696392

Public ClinicalTrials.gov record NCT05696392. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Single-Arm, Phase 4 Study of Ruxolitinib Cream in Adults With Atopic Dermatitis Experiencing Sleep Disturbance in the United States (MORPHEUS)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate the effect of ruxolitinib cream on sleep disturbances with participants with Atopic Dermatitis.

Study identification

NCT ID
NCT05696392
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Incyte Corporation
Industry
Enrollment
47 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 16, 2023 (Actual)
Primary completion
Jan 22, 2025 (Actual)
Completion
Jan 22, 2025 (Actual)
Last update posted
Dec 19, 2025

2023 – 2025

United States locations

U.S. sites
30
U.S. states
16
U.S. cities
29
Facility City State ZIP Site status
First Oc Dermatology Fountain Valley California 92708 —
Ark Clinical Research Long Beach California 90815 —
Gw Training Center Washington D.C. District of Columbia 20037 —
Skin Care Research, Llc Boca Raton Florida 33486 —
Driven Research Llc Coral Gables Florida 33134 —
University of Florida Health Dermatology-Springhill Gainesville Florida 32606 —
Skin Care Research, Llc Scr Hollywood Hollywood Florida 33021 —
Ciocca Dermatology Pa Miami Florida 33173 —
Trueblue Clinical Research Tampa Florida 33609 —
Dermatology Specialists Research Indiana Clarksville Indiana 47129 —
Dawes Fretzin Clinical Research Group Llc Indianapolis Indiana 46250 —
Skin Sciences Pllc Louisville Kentucky 40217 —
Beth Israel Deaconess Medical Center (Bidmc) Boston Massachusetts 02215 —
Northeast Dermatology Associates Methuen Massachusetts 01844 —
Essential Dermatology Natick Massachusetts 01760 —
Washington University School of Medicine Dermatology St Louis Missouri 63110 —
Suny Downstate Health Sciences University Brooklyn New York 11203 —
Empire Dermatology East Syracuse New York 13057 —
Sadick Dermatology New York New York 10075 —
Skin Search of Rochester Rochester New York 14623 —
Ohio Pediatric Research Association Dayton Ohio 45414 —
Oregon Dermatology and Research Center Portland Oregon 97210 —
Knight Cancer Institute At Oregon Health and Science University Portland Oregon 97239 —
University of Pittsburgh Pittsburgh Pennsylvania 15213 —
Clinical Research Center of the Carolinas Charleston South Carolina 29407 —
Arlington Research Center Arlington Texas 76011 —
Jordan Valley Dermatology Center South Jordan Utah 84095 —
Pi Coor Clinical Research Llc Burke Virginia 22015 —
Clinical Research Partners Llc Richmond Virginia 23226 —
Dermatology Specialists of Spokane Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05696392, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 19, 2025 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05696392 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →